Dent Neurologic

DENTNeuro_White

DENT Neurosciences Research Center

The Dent Neuroscience Research Center (DNRC) is a 501(c)(3) not-for-profit affiliate of DENT dedicated to outcomes research and education supported by foundations, industry and personal contributions. The DNRC is focused on developing comprehensive, clinically relevant, and cost effective solutions to complex neurological problems faced in our community.

Building awareness, fostering relationships, providing support and continuous education are at the forefront of the DENT philosophy. From providing our patients with the most up-to-date diagnostic and treatment options to assisting each in the best care and coping opportunities, we aim to fulfill the needs of the whole patient. Through foundation support and exceptional faculty leadership, DNRC is able to build upon the philosophy by providing advancement, support and education to our providers and partners.

Open Studies

Want to participate in a study?

Please call 716-250-2009 and one of our Research Coordinators will be in contact with you as soon as possible. If we currently do not have a study that is currently available for you, we will add you to our database for future studies.

  • All
  • Alzheimer's
  • Behavioral Health
  • Dizziness and Balance
  • Epilepsy
  • Headache/Migraine
  • Multiple Sclerosis
  • Parkisons Disease
  • Research Study
  • Stroke Center
  • Treatment-Resistant Depression
  • Uncategorized
All
  • All
  • Alzheimer's
  • Behavioral Health
  • Dizziness and Balance
  • Epilepsy
  • Headache/Migraine
  • Multiple Sclerosis
  • Parkisons Disease
  • Research Study
  • Stroke Center
  • Treatment-Resistant Depression
  • Uncategorized
Multiple Sclerosis

SANOFI EFC17504

SANOFI EFC17504 The purpose of this study is to determine ...
Read More →
Multiple Sclerosis

PIPELINE/CONTINUUM VISTA

PIPELINE/CONTINUUM VISTA This is a randomized, double-blind study of PIPE-307 ...
Read More →
Research Study

INDIVIOR INDV-6000-406

INDIVIOR INDV-6000-406 This study will provide the opportunity to generate ...
Read More →
Parkisons Disease

Jazz Patagonia

JAZZ PATAGONIA (Parkinson’s Disease) This is a 17-week double-blind, placebo-controlled, ...
Read More →
Alzheimer's

IGC Pharma

IGC PHARMA (Alzheimer’s Disease with Agitation) This is a trial ...
Read More →
Alzheimer's

ACADIA RADIANT

ACADIA RADIANT (Alzheimer’s Disease Psychosis) In this study, researchers will ...
Read More →
Alzheimer's

SUVEN CTP3S1502HT6

SUVEN CTP3S1502HT6 (Alzheimer’s Disease with Agitation) This study will be ...
Read More →
Alzheimer's

BIOGEN CELIA

BIOGEN CELIA In this study, researchers will learn more about ...
Read More →
Alzheimer's

ADCS BENFO-TEAM

ADCS BENFO-TEAM The purpose of this study is to learn ...
Read More →
Research Study

OXA1 Study

0XA1 Study This study will test if an investigational medicine ...
Read More →
Uncategorized

CogMS

CogMS – A Real-world Study Into Cognitive Impairment in People ...
Read More →
Research Study

Generation HD-2

Generation HD-2 This study will evaluate the safety, biomarkers, and ...
Read More →
Uncategorized

ENVISION

ENVISION Trial  The objective of this study is to verify ...
Read More →
Uncategorized

PROSEEK

PROSEEK To Potentially Help Slow Progression for People with Early-stage ...
Read More →
Uncategorized

NRX- 101

Testing the hypothesis that treatment with NRX-101 is superior to standard of care (lurasidone) in improving symptoms of depression as measured by the total Montgomery ...
Read More →
Uncategorized

ADNI4 Trial

ADNI4 Trial The ADNI4 is multi-center, a non-randomized, natural history, ...
Read More →
Uncategorized

Descartes-08

Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis
Read More →
Dizziness and Balance

Hearing Aid Research

Hearing Aid Research Are you interested in participating in hearing ...
Read More →
Uncategorized

Meniere’s Study

Meniere’s Study Have you been diagnosed with Meniere’s Disease? Do ...
Read More →
Epilepsy

STARS and STARS Extension

Studies to Assess the Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
Read More →
Uncategorized

RETHINK-ALZ

Simufilam 100 mg for Mild to Moderate Alzheimer's Disease
Read More →

Research at Dent

The mission of research at DENT is to advance patient care by integrating the newest scientific advances into daily clinical practice. With support from organizations such as the Dent Family Foundation, the Blaszczykiewicz Foundation, and pharmaceutical clinical trials, DENT has established an impressive portfolio of publications and presentations in the scientific and clinical community.

Participating in research and clinical trials often provides an opportunity for patients to receive free medical care and medication. To learn if you might qualify, please visit Current Research Studies.

For research sponsors and investigators, we offer the opportunity to partner with an experienced team of researchers engaged in cutting-edge clinical practice and research in a wide variety of neurological disciplines.

Past & current research studies:

  • ALS (Lou Gehrig’s Disease)
  • Alzheimer’s Disease
  • Epilepsy
  • Memory Loss/Dementia
  • Migraine
  • Multiple Sclerosis
  • Neuroimaging
  • Neuro-oncology
  • Neuropathic Pain
  • Nuclear Medicine
  • Parkinson’s Disease
  • Psychiatry
  • Stroke
  • Vertigo

DNRC

Leadership

- Laszlo Mechtler, MD, Chief Medical Officer

- Fran M. Gengo, Pharm.D., Chief Science Officer

- Michelle Rainka, Pharm.D., CCRP, Secretary

- Joseph V. Fritz, Ph.D., Chief Administrative Executive

- Harry M. Dent III, Community Representative

- Maureen Tomczak-Griffin, Community Representative

- Anthony Baynes, Community Representative

The goal of DNRC is to advance neurologic care through pragmatic research and education at local, national and international levels.

Past Studies

Giving Opportunities

The DNRC is funded through industry grants and clinical trial contracts, foundations, and community donations. Funds support need-based deserving initiatives related to the diagnosis and treatment of neurological disorders in patients from around the Western New York region.

Corporate or individual donors are welcome to designate their contribution to a specific specialty fund or have it applied to the general operating needs where it is most effective. Gifts can be made in many forms, including cash donations, proceeds from community benefits, corporate contributions and matching gifts, grants, planned gifts, gifts of honor or memorials, and more.

Please contact Maria Caserta, mcaserta@dentinstitute.com, to find out more about how you can help support our mission to bring the most comprehensive treatments to our neighbors and their families suffering with neurological disorders.

Scroll to Top